(CNN) — The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription ...

Opportunities in the pain market include developing NaV inhibitors like NaV1.8 and NaV1.7, diversifying pain therapeutics by molecule type, and capitalizing on the fast-growing nociceptive pain sector ...

Joint pain can be caused by a number of biological, psychological, and social factors. The most common cause of joint pain is ...

WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin ...

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals. The drug, Journavx, or suzetrigine, was approved to treat moderate to severe acute ...

Nerve pain affects millions of people worldwide, creating a burning, shooting, or electric sensation that can make daily activities nearly impossible. Unlike regular pain that responds well to common ...

The four medications tested in the study were nortriptyline, duloxetine, pregabalin, and mexiletine. Each of these drugs is ...

As opioid pain medications continue being prescribed for chronic and severe pain, understanding their risks becomes increasingly crucial. While these pills may offer temporary relief, their potential ...

Discover how radiofrequency ablation offers long-term pain relief for chronic sufferers, bridging the gap between temporary solutions and sustainable management.